I Lilja1, C Gustafson-Svärd, L Franzén, R Sjödahl. 1. Department of Biomedicine and Surgery, Division of Surgery, Linköping University, Faculty of Health Sciences, Linköping, Sweden.
Abstract
BACKGROUND: Reports that both intestinal and extraintestinal Crohn's disease (CD) had healed successfully after treatment with anti-tumor necrosis factor-alpha (TNF-alpha) antibody have strengthened the hypothesis that it has a role in the treatment of CD. The macrophage is one source of TNF-alpha. Intestinal mast cells are also thought to have a role in CD, but it is not known if human ileal mast cells express TNF-alpha. AIM: To find out whether TNF-alpha is expressed by mast cells in the ileal wall in CD patients and controls. METHODS: TNF-alpha was sought immunohistochemically in full thickness specimens of ileal wall from patients with CD (histologically normal, n = 9; inflamed, n = 6) and controls (patients with colonic cancer, n = 8). Mast cells were identified by metachromasia and anti-mast cell tryptase immunoreactivity. RESULTS: In all layers of the ileal wall, and in every specimen investigated, mast cells were the main cell type that expressed TNF-alpha immunoreactivity out of the TNF-alpha-labelled cells. The number of TNF-alpha- labelled mast cells was greater in the muscularis propria in patients compared with controls, both in uninflamed (1.7-fold, p < 0.05) and in inflamed bowel (4.6-fold, p < 0.002); greater in the submucosa in inflamed compared with uninflamed CD (1.6-fold, p < 0. 01), and less in the lamina propria in inflamed compared with uninflamed CD (0.4-fold, p < 0.05). CONCLUSION: Mast cells are an important source of TNF-alpha in all layers of the ileal wall, and the increased density of TNF-alpha-positive mast cells in the submucosa and muscularis propria may contribute to the tissue changes and symptoms in CD. Copyright 2000 S. Karger AG, Basel
BACKGROUND: Reports that both intestinal and extraintestinal Crohn's disease (CD) had healed successfully after treatment with anti-tumor necrosis factor-alpha (TNF-alpha) antibody have strengthened the hypothesis that it has a role in the treatment of CD. The macrophage is one source of TNF-alpha. Intestinal mast cells are also thought to have a role in CD, but it is not known if human ileal mast cells express TNF-alpha. AIM: To find out whether TNF-alpha is expressed by mast cells in the ileal wall in CDpatients and controls. METHODS:TNF-alpha was sought immunohistochemically in full thickness specimens of ileal wall from patients with CD (histologically normal, n = 9; inflamed, n = 6) and controls (patients with colonic cancer, n = 8). Mast cells were identified by metachromasia and anti-mast cell tryptase immunoreactivity. RESULTS: In all layers of the ileal wall, and in every specimen investigated, mast cells were the main cell type that expressed TNF-alpha immunoreactivity out of the TNF-alpha-labelled cells. The number of TNF-alpha- labelled mast cells was greater in the muscularis propria in patients compared with controls, both in uninflamed (1.7-fold, p < 0.05) and in inflamed bowel (4.6-fold, p < 0.002); greater in the submucosa in inflamed compared with uninflamed CD (1.6-fold, p < 0. 01), and less in the lamina propria in inflamed compared with uninflamed CD (0.4-fold, p < 0.05). CONCLUSION: Mast cells are an important source of TNF-alpha in all layers of the ileal wall, and the increased density of TNF-alpha-positive mast cells in the submucosa and muscularis propria may contribute to the tissue changes and symptoms in CD. Copyright 2000 S. Karger AG, Basel
Authors: Jaime García de Tena; Luis Manzano; Juan Carlos Leal; Esther San Antonio; Verónica Sualdea; Melchor Alvarez-Mon Journal: J Clin Immunol Date: 2006-05-02 Impact factor: 8.317
Authors: Antonio M Scanu; Tim J Bull; Sara Cannas; Jeremy D Sanderson; Leonardo A Sechi; Giuseppe Dettori; Stefania Zanetti; John Hermon-Taylor Journal: J Clin Microbiol Date: 2007-10-03 Impact factor: 5.948
Authors: H Kim; L Dwyer; J H Song; F E Martin-Cano; J Bahney; L Peri; F C Britton; K M Sanders; S D Koh Journal: Neurogastroenterol Motil Date: 2011-08-01 Impact factor: 3.598
Authors: David S Kotlyar; Mili Shum; Jennifer Hsieh; Wojciech Blonski; David A Greenwald Journal: World J Gastroenterol Date: 2014-08-28 Impact factor: 5.742
Authors: J D Söderholm; C Streutker; P-C Yang; C Paterson; P K Singh; D M McKay; P M Sherman; K Croitoru; M H Perdue Journal: Gut Date: 2004-12 Impact factor: 23.059